- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00218270
Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use
Treatment of Smokeless Tobacco Users
Study Overview
Detailed Description
Spit tobacco presents as many health risks to its users as smoking tobacco. Although a significant number of ST users recognize the importance of quitting, many either do not want to quit or feel it is impossible. For these individuals, tobacco reduction may be an important transitional goal, either prior to quitting or as a treatment endpoint. However, approaches to help ST users reach this goal have not been studied. This study will assess the effectiveness of using tobacco-free snuff in reducing levels of exposure to tobacco and associated toxicity, as well as enhancing motivation to either quit or sustain lower levels of nicotine intake.
Participants will be randomly assigned to receive either treatment with tobacco-free snuff or treatment without it. All participants will be encouraged to reduce nicotine intake by 50% during the first four weeks and by 75% the following four weeks. Participants receiving the tobacco-free snuff will be asked to alternate the use of their usual brand of ST with tobacco-free snuff in order to achieve the targeted reduction. Participants not receiving the tobacco-free snuff will only be informed to try to cut down their tobacco use to the targeted reduction. Study visits will occur once weekly during the 8-week treatment period. Assessments will include vital signs, physiological measures related to tobacco use, and measures of motivation and self-efficacy to quit ST. The number of participants who either do not complete treatment, reduce nicotine intake, or quit completely will be assessed at the Week 8 study visit and at follow-up visits, which will be held at Weeks 12 and 26.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Not interested in quitting smokeless tobacco use within 90 days of study entry
- Used smokeless tobacco at least six times a day for 6 months prior to study entry
- Agree to use an effective form of contraception throughout the study
Exclusion Criteria:
- Current use of tobacco or nicotine products other than ST
- Pregnant or breastfeeding
- Any unstable medical condition
- Use of any medication that may affect tobacco use or be affected by reduction of tobacco use
- DSM-IV diagnosis of any psychiatric disorders or substance abuse disorders within 6 months prior to study entry
- Use of any psychotropic medications within 6 months prior to study entry
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: 1
Reduction of tobacco use by substituting tobacco free snuff.
|
Tobacco free snuff
Other Names:
|
PLACEBO_COMPARATOR: 2
Reduction of tobacco use by using behavioral techniques.
|
Tobacco free snuff
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percent reduction in use
Time Frame: Week 8, 12, and 26
|
Week 8, 12, and 26
|
Toxicity profile of carcinogen metabolites
Time Frame: Week 8, 12, and 26
|
Week 8, 12, and 26
|
Number of unsuccessful quit attempts
Time Frame: Week 8, 12, and 26
|
Week 8, 12, and 26
|
Abstinence (measured at Weeks 8, 12, and 26)
Time Frame: Week 8, 12, and 26
|
Week 8, 12, and 26
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Motivation and self-efficacy (measured at Weeks 8, 12, and 26)
Time Frame: Week 8, 12, and 26
|
Week 8, 12, and 26
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIDA-14404-2
- DPMC (Other Identifier: NIDA)
- R01-14404-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use Disorder
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco DependenceUnited States
-
Harvard School of Public Health (HSPH)Beacon Communities; The Community BuildersEnrolling by invitationTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Second Hand Tobacco SmokeUnited States
-
University of California, San FranciscoNational Institute on Minority Health and Health Disparities (NIMHD)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramCompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, CigaretteUnited States
-
New York State Psychiatric InstituteTerminatedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Nicotine Dependence | Cigarette Smoking | Tobacco Dependence | Nicotine Use Disorder | Smoking, CigaretteUnited States
-
Rutgers, The State University of New JerseyNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Schizoaffective Disorder | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use CessationUnited States
-
University of PennsylvaniaFood and Drug Administration (FDA)Completed
-
University of Kansas Medical CenterCompletedTobacco Use Disorder/Cigarette SmokingUnited States
-
Ottawa Hospital Research InstituteCompletedTobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence
Clinical Trials on Tobacco free snuff
-
RAI Services CompanyCompleted
-
Glorian SorensenHealis-Sekhsaria Institute for Public HealthCompletedTobacco Use CessationUnited States, India
-
Harvard School of Public Health (HSPH)University of Minnesota; HealthCore-NERI; Healis-Sekhsaria Institute for Public... and other collaboratorsCompleted
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedTobacco Prevention and CessationUnited States
-
Oregon Research InstituteCompletedTobacco Smoking | Health PromotionUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedTobacco Use Cessation | Smoking Behaviors | Health DisparityUnited States
-
Mayo ClinicNational Institutes of Health (NIH)CompletedTobacco DependenceUnited States
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); Dana-Farber Cancer Institute; HealthCore-NERI; Healis-Sekhsaria Institute for Public HealthCompleted
-
Tata Memorial HospitalUnknown
-
Florida International UniversityCompleted